Scientists test mRNA tech, like COVID vaccines, to fight blood cancers
NCT ID NCT07349849
Summary
This early-stage study is testing a new type of drug that uses mRNA technology, similar to some COVID-19 vaccines, to treat B-cell blood cancers like leukemia and lymphoma that have not responded to standard treatments. The drug is designed to target a protein called CD19 found on these cancer cells. Researchers will first determine the safest dose and look for early signs that the treatment can help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Hematology, Xinqiao Hospital
RECRUITINGChongqing, Chongqing Municipality, 400037, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.